Evidence map›Paper›PMID 41012785›Full record

ReviewVeterinary sciences2025

Genetic Diversity of Newcastle Disease Virus and Its Implications for Vaccine Development.

Olga A Kondakova, Alexey A Agranovsky, Ekaterina M Ryabchevskaya, Elizaveta P Umarova, Dmitriy L Granovskiy, Stepan E Toropov, Ekaterina A Evtushenko, Nikolai A Nikitin, Olga V Karpova

Abstract readReview
In one paragraph

Review in Veterinary sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Olga A KondakovaDepartment of Virology, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0001-5134-6624
Alexey A AgranovskyDepartment of Virology, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.
Ekaterina M RyabchevskayaDepartment of Virology, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0003-2683-8285
Elizaveta P UmarovaDepartment of Virology, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0009-0005-8923-9687
Dmitriy L GranovskiyDepartment of Virology, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.
Stepan E ToropovDepartment of Virology, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.
Ekaterina A EvtushenkoDepartment of Virology, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0002-0679-6818
Nikolai A NikitinDepartment of Virology, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0001-9626-2336
Olga V KarpovaDepartment of Virology, Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0002-0605-9033

Funding

Russian Science Foundation 25-14-00045
6 · The paper itself

Abstract

The Newcastle disease virus (NDV), an avian paramyxovirus, induces the highly contagious Newcastle disease in poultry. Newcastle disease outbreaks, common in many developing countries, have been recorded worldwide for a century. Poultry, even vaccinated stocks, together with wild and synanthropic birds, serve as reservoirs of NDV. Despite the extensive use of commercial NDV vaccines, Newcastle disease outbreaks frequently occur in vaccinated chickens, resulting in great economic losses. The primary limitation of commercial Newcastle disease vaccines is their restricted compatibility with emerging novel NDV strains. The advancement of vaccines and vaccination techniques is anticipated to reduce the propagation of pathogenic NDV strains and consequently alleviate losses in poultry production. This review examines the NDV genotypes and strains implicated in both current and historical Newcastle disease outbreaks, and evaluates existing and candidate NDV vaccines, emphasizing recent innovations and novel techniques. Our aim was to delineate critical subjects for future inquiry and to furnish extensive data that could aid researchers in understanding the current advancements and existing problems in Newcastle disease vaccination prophylactics. The emergence of a new generation of vaccines employing advanced technologies may substantially improve the efficacy of Newcastle disease prevention and control.

Indexed as

genotypesNewcastle disease virusvaccines

Identifiers

PMID41012785
PMCPMC12474166

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.